Breakthrough therapy Sponsored Post:
The US FDA appears to be supportive of psilocybin research. In 2018, for example, they recognized psilocybin as potentially a “breakthrough therapy” for depression. Clinical studies from prestigious institutions such as Johns Hopkins Medicine and New York University also appear to be showing positive results. Check the disclaimer on my profile and landing page